AA
ACOR
AlphaMark Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-36,748
| Closed | -$691K | – | 520 |
|
|
2016
Q4 | $691K | Hold |
36,748
| – | – | 0.36% | 62 |
|
|
2016
Q3 | $767K | Buy |
36,748
+13,700
| +59% | +$286K | 0.39% | 65 |
|
|
2016
Q2 | $588K | Hold |
23,048
| – | – | 0.35% | 68 |
|
|
2016
Q1 | $610K | Sell |
23,048
-7,336
| -24% | -$194K | 0.32% | 64 |
|
|
2015
Q4 | $1.3M | Buy |
30,384
+8,384
| +38% | +$359K | 0.66% | 45 |
|
|
2015
Q3 | $583K | Hold |
22,000
| – | – | 0.32% | 66 |
|
|
2015
Q2 | $733K | Buy |
+22,000
| New | +$733K | 0.41% | 67 |
|